Apixaban is a direct factor Xa inhibitor that reduces the risk of stroke and blood clot formation.
Apixaban is an oral anticoagulant belonging to the class of direct factor Xa inhibitors. It helps reduce the blood’s ability to form clots, which can lower the risk of serious blockages in arteries and veins. This ingredient is found in products such as Eliquis that are approved for use in Hong Kong.
Eliquis is the most widely known brand that contains apixaban. It is supplied as film-coated tablets in two strengths - 2.5 mg and 5 mg - and is available by prescription from the Pharmacy and Poisons Board of Hong Kong. Generic versions of apixaban may also be dispensed, but they contain the same active ingredient and work in the same way as Eliquis. The tablets can be taken with or without food.
These uses are based on approval from Hong Kong’s health authorities and reflect the situations in which apixaban has been shown to be effective.
Apixaban blocks the activity of factor Xa, a protein that plays a key role in the cascade that creates blood clots. By limiting factor Xa, the medication slows the formation of fibrin, the mesh-like substance that holds clots together. The result is a steadier flow of blood through vessels, which helps prevent blockages without completely stopping clotting. Most people feel the anticoagulant effect within a few hours after taking a tablet.
These effects are usually temporary and resolve without medical intervention.
If any of these signs appear, seek urgent medical attention.
For a complete list of possible interactions, refer to the specific medication’s information leaflet.
Store Eliquis tablets in a cool, dry place away from direct sunlight and out of reach of children. The usual treatment length can vary-from a few weeks for short-term clot treatment to indefinite use for chronic stroke prevention. Always read the product label and follow the directions provided with your specific medication. For detailed usage, dosing, and administration, refer to your individual product’s information.
Anticoagulant: A medicine that slows the blood’s ability to clot. Factor Xa: A protein in the clotting process that apixaban blocks. Atrial fibrillation: An irregular heart rhythm that can increase stroke risk. Deep-vein thrombosis (DVT): A clot that forms in a deep vein, usually in the leg. Pulmonary embolism (PE): A clot that travels to and blocks a vessel in the lungs.
This article offers general educational information about apixaban as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing apixaban may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow the guidance of a qualified healthcare professional for complete information on proper use, dosage, and safety.